Collectively, these findings indicate that EC-specific deletion of Mlkl effectively alleviates liver fibrosis in NASH by suppressing the activation of the TGFβ/Smad 2/3 pathway and disrupting the pro-fibrotic crosstalk between endothelial cells and HSCs. The gene discussed is MLKL; the disease is Hepatic fibrosis.